The cell biology of cross-presentation and the role of dendritic cell subsets

Immunology and Cell Biology

Volumn 86, Issue 4, 2008, Pages 353-362

  Lin, Ming Lee ^a   Zhan, Yifan ^a   Villadangos, Jose A ^a   Lew, Andrew M ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cross presentation; Cytosolic pathway; Dendritic cells; Migratory; Resident

Indexed keywords

GLYCOPROTEIN; MANNOSE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CD8+ T LYMPHOCYTE; CELL ORGANELLE; CELL VACUOLE; CROSS PRESENTATION; CYTOLOGY; CYTOSOL; DENDRITIC CELL; ENDOSOME; HUMAN; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MEMORY T LYMPHOCYTE; NONHUMAN; PHAGOCYTOSIS; REVIEW; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

ANTIGEN PRESENTATION; ANTIGENS; CROSS-PRIMING; DENDRITIC CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX;

EID: 43449108856     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.3     Document Type: Review

References (148)

1. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976; 143: 1283-1288.
2. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998; 188: 1359-1368.
3. Schulz O, Reis e Sousa C. Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 2002; 107: 183-189.
4. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195: 1289-1302.
5. Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, Papworth GD et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101: 611-620.
6. Miyake Y, Asano K, Kaise H, Uemura M, Nakayama M, Tanaka M. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J Clin Invest 2007; 117: 2268-2278.
7. + dendritic cells. J Immunol 2001; 166: 5327-5330.
8. den Haan JM, Lehar SM, Bevan MJ. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000; 192: 1685-1696.
9. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 2006; 103: 10729-10734.
10. Schulz O, Pennington DJ, Hodivala-Dilke K, Febbraio M, Reis e Sousa C. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells. J Immunol 2002; 168: 6057-6065.
11. + splenic dendritic cells but is not required for cross-presentation in vivo. J Immunol 2002; 168: 6066-6070.
12. Guermonprez P, Amigorena S. Pathways for antigen cross presentation. Springer Semin Immunopathol 2005; 26: 257-271.
13. den Haan JM, Bevan MJ. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med 2002; 196: 817-827.
14. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007; 316: 612-616.
15. Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004; 199: 815-824.
16. Weck MM, Appel S, Werth D, Sinzger C, Bringmann A, Grunebach F et al. hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 2007; e-pub ahead of print.
17. Bendz H, Ruhland SC, Pandya MJ, Hainzl O, Riegelsberger S, Brauchle C et al. Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling. J Biol Chem 2007; 282: 31688-31702.
18. Chaput N, Flament C, Viaud S, Taieb J, Roux S, Spatz A et al. Dendritic cell derived-exosomes: biology and clinical implementations. J Leukoc Biol 2006; 80: 471-478.
19. Graham DB, Stephenson LM, Lam SK, Brim K, Lee HM, Bautista J et al. An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells. J Exp Med 2007; 204: 2889-2897.
20. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005; 23: 975-1028.
21. Villadangos JA, Schnorrer P, Wilson NS. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol Rev 2005; 207: 191-205.
22. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005; 307: 1630-1634.
23. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 2006; 126: 205-218.
24. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998; 93: 1135-1145.
25. Ni J, Fernandez MA, Danielsson L, Chillakuru RA, Zhang J, Grubb A et al. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem 1998; 273: 24797-24804.
26. Halfon S, Ford J, Foster J, Dowling L, Lucian L, Sterling M et al. Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J Biol Chem1998; 273: 16400-16408.
27. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 2003; 299: 1400-1403.
28. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997; 388: 787-792.
29. Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, Reis e Sousa C et al. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 2000; 191: 927-936.
30. Itano AA, Jenkins MK. Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol 2003; 4: 733-739.
31. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003; 19: 47-57.
32. Mills EN, Jenkins JA, Alcocer MJ, Shewry PR. Structural, biological, and evolutionary relationships of plant food allergens sensitizing via the gastrointestinal tract. Crit Rev Food Sci Nutr 2004; 44: 379-407.
33. + T cell responses against soluble antigens in vivo. J Exp Med 2005; 202: 817-828.
34. Vulcano M, Dusi S, Lissandrini D, Badolato R, Mazzi P, Riboldi E et al. Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. J Immunol 2004; 173: 5749-5756.
35. Arnold D, Faath S, Rammensee H, Schild H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995; 182: 885-889.
36. Fonteneau JF, Kavanagh DG, Lirvall M, Sanders C, Cover TL, Bhardwaj N et al. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 2003; 102: 4448-4455.
37. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995; 267: 243-246.
38. Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001; 166: 6099-6103.
39. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 1995; 3: 783-791.
40. Reis e Sousa C, Germain RN. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 1995; 182: 841-851.
41. Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 2004; 21: 155-165.
42. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev 2005; 207: 166-183.
43. Delamarre L, Holcombe H, Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 2003; 198: 111-122.
44. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999; 1: 362-368.
45. Shen L, Rock KL. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol 2006; 18: 85-91.
46. Wilson NS, Villadangos JA. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv Immunol 2005; 86: 241-305.
47. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 2005; 207: 145-157.
48. Brossart P, Bevan MJ. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997; 90: 1594-1599.
49. Nuchtern JG, Bonifacino JS, Biddison WE, Klausner RD. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 1989; 339: 223-226.
50. + T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J Immunol 2006; 177: 3525-3533.
51. Pierre P. Dendritic cells, DRiPs, and DALIS in the control of antigen processing. Immunol Rev 2005; 207: 184-190.
52. Tsai B, Ye Y, Rapoport TA. Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol 2002; 3: 246-255.
53. Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004; 429: 841-847.
54. Lilley BN, Ploegh HL. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004; 429: 834-840.
55. Imai J, Hasegawa H, Maruya M, Koyasu S, Yahara I. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells. Int Immunol 2005; 17: 45-53.
56. Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006; 25: 607-617.
57. Van den Berg B, Clemons Jr WM, Collinson I, Modis Y, Hartmann E, Harrison SC et al. X-ray structure of a protein-conducting channel. Nature 2004; 427: 36-44.
58. Rock KL. Exiting the outside world for cross-presentation. Immunity 2006; 25: 523-525.
59. Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 1997; 27: 280-288.
60. + subset. Proc Natl Acad Sci USA 2008 (in press).
61. Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 2003; 425: 402-406.
62. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci USA 2003; 100: 12889-12894.
63. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003; 425: 397-402.
64. Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, Steele-Mortimer O et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 2002; 110: 119-131.
65. Garin J, Diez R, Kieffer S, Dermine JF, Duclos S, Gagnon E et al. The phagosome proteome: insight into phagosome functions. J Cell Biol 2001; 152: 165-180.
66. Schmitz A, Herrgen H, Winkeler A, Herzog V. Cholera toxin is exported from microsomes by the Sec61p complex. J Cell Biol 2000; 148: 1203-1212.
67. Roy CR. Exploitation of the endoplasmic reticulum by bacterial pathogens. Trends Microbiol 2002; 10: 418-424.
68. + Tcells in vivo: the key to rational vaccine design. Annu Rev Immunol 2005; 23: 651-682.
69. Touret N, Paroutis P, Terebiznik M, Harrison RE, Trombetta S, Pypaert M et al. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 2005; 123: 157-170.
70. Russell DG. Phagosomes, fatty acids and tuberculosis. Nat Cell Biol 2003; 5: 776-778.
71. Cossart P, Sansonetti PJ. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004; 304: 242-248.
72. Groothuis TAM, Neefjes J. The many roads to cross-presentation. J Exp Med 2005; 202: 1313-1318.
73. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat Immunol 2005; 6: 107-113.
74. Schirmbeck R, Reimann J. Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire. Mol Immunol 2002; 39: 249-259.
75. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993; 361: 359-362.
76. Song R, Harding CV. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol 1996; 156: 4182-4190.
77. Wick MJ, Pfeifer JD. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur J Immunol 1996; 26: 2790-2799.
78. Abdel Motal UM, Zhou X, Joki A, Siddiqi AR, Srinivasa BR, Stenvall K et al. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization. Eur J Immunol 1993; 23: 3224-3229.
79. Gromme M, Uytdehaag FG, Janssen H, Calafat J, van Binnendijk RS, Kenter MJ et al. Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci USA 1999; 96: 10326-10331.
80. + T cells in vivo. J Immunol 2001; 166: 4355-4362.
81. Ruedl C, Storni T, Lechner F, Bachi T, Bachmann MF. Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP. Eur J Immunol 2002; 32: 818-825.
82. Sigal LJ, Rock KL. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J Exp Med 2000; 192: 1143-1150.
83. Chapman HA. Endosomal proteases in antigen presentation. Curr Opin Immunol 2006; 18: 78-84.
84. Shen H, Ackerman AL, Cody V, Giodini A, Hinson ER, Cresswell P et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 2006; 117: 78-88.
85. Desjardins M, Houde M, Gagnon E. Phagocytosis: the convoluted way from nutrition to adaptive immunity. Immunol Rev 2005; 207: 158-165.
86. Boes M, van der Wel N, Peperzak V, Kim YM, Peters PJ, Ploegh H. In vivo control of endosomal architecture by class II-associated invariant chain and cathepsin S. Eur J Immunol 2005; 35: 2552-2562.
87. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-89.
88. Harding CV, Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 1994; 153: 4925-4933.
89. Ke Y, Kapp JA. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. J Exp Med 1996; 184: 1179-1184.
90. + T cell responses to bacterial antigens. J Immunol 2004; 173: 1994-2002.
91. Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004; 199: 9-26.
92. Carbone FR, Bevan MJ. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 1990; 171: 377-387.
93. Smith CM, Belz GT, Wilson NS, Villadangos JA, Shortman K, Carbone FR et al. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J Immunol 2003; 170: 4437-4440.
94. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002; 17: 211-220.
95. Grant EP, Rock KL. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo. J Immunol 1992; 148: 13-18.
96. Probst HC, Tschannen K, Odermatt B, Schwendener R, Zinkernagel RM, Van Den Broek M. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol 2005; 141: 398-404.
97. + T cells by infected dendritic cells in vivo. Nat Immunol 2002; 3: 265-271.
98. Pozzi L-AM, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol 2005; 175: 2071-2081.
99. Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, Lebon P et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007; 27: 481-492.
100. Salio M, Palmowski MJ, Atzberger A, Hermans IF, Cerundolo V. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med 2004; 199: 567-579.
101. Schnurr M, Chen Q, Shin A, Chen W, Toy T, Jenderek C et al. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood 2005; 105: 2465-2472.
102. Caminschi I, Ahmet F, Heger K, Brady J, Nutt SL, Vremec D et al. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med 2007; 204: 2579-2590.
103. Vosshenrich CA, Lesjean-Pottier S, Hasan M, Richard-Le Goff O, Corcuff E, Mandelboim O et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 2007; 204: 2569-2578.
104. Villadangos JA, Heath WR. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin Immunol 2005; 17: 262-272.
105. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2: 151-161.
106. Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 1997; 159: 565-573.
107. McLellan AD, Kapp M, Eggert A, Linden C, Bommhardt U, Brocker EB et al. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 2002; 99: 2084-2093.
108. Douillard P, Stoitzner P, Tripp CH, Clair-Moninot V, Ait-Yahia S, McLellan AD et al. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J Invest Dermatol 2005; 125: 983-994.
109. El-Sukkari D, Wilson NS, Hakansson K, Steptoe RJ, Grubb A, Shortman K et al. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J Immunol 2003; 171: 5003-5011.
110. Allan RS, Smith CM, Belz GT, van Lint AL, WakimLM, Heath WR et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003; 301: 1925-1928.
111. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25: 153-162.
112. Belz GT, Smith CM, Eichner D, Shortman K, Karupiah G, Carbone FR et al. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol 2004; 172: 1996-2000.
113. Moron G, Rueda P, Casal I, Leclerc C. CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med 2002; 195: 1233-1245.
114. Belz GT, Smith CM, Kleinert L, Reading P, Brooks A, Shortman K et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci USA 2004; 101: 8670-8675.
115. Vingert B, Adotevi O, Patin D, Jung S, Shrikant P, Freyburger L et al. The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity. Eur J Immunol 2006; 36: 1124-1135.
116. Belz GT, Shortman K, Bevan MJ, Heath WR. CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J Immunol 2005; 175: 196-200.
117. Belz GT, Heath WR, Carbone FR. The role of dendritic cell subsets in selection between tolerance and immunity. Immunol Cell Biol 2002; 80: 463-468.
118. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003; 197: 153-162.
119. + T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med 2003; 198: 201-209.
120. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 2002; 196: 1079-1090.
121. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D et al. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 2002; 16: 169-181.
122. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997; 186: 239-245.
123. Davey GM, Kurts C, Miller JF, Bouillet P, Strasser A, Brooks AG et al. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med 2002; 196: 947-955.
124. Morgan DJ, Kurts C, Kreuwel HT, Holst KL, Heath WR, Sherman LA. Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci USA 1999; 96: 3854-3858.
125. Kurts C, Sutherland RM, Davey G, Li M, Lew AM, Blanas E et al. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci USA 1999; 96: 12703-12707.
126. Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, Lejon K et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002; 196: 1099-1104.
127. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002; 196: 1091-1097.
128. + T cell tolerance. J Exp Med 2002; 196: 1627-1638.
129. Chung Y, Chang J-H, Kweon M-N, Rennert PD, Kang C-Y. CD8{alpha}-11b+ dendritic cells but not CD8{alpha}+ dendritic cells mediate cross-tolerance toward intestinal antigens. Blood 2005; 106: 201-206.
130. Waithman J, Allan RS, Kosaka H, Azukizawa H, Shortman K, Lutz MB et al. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J Immunol 2007; 179: 4535-4541.
131. Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, Bursch L et al. Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 2006; 103: 7783-7788.
132. O'Connell PJ, Son YI, Giermasz A, Wang Z, Logar AJ, Thomson AW et al. Type-1 polarized nature of mouse liver CD8alpha- and CD8alpha+ dendritic cells: tissue-dependent differences offset CD8alpha-related dendritic cell heterogeneity. Eur J Immunol 2003; 33: 2007-2013.
133. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001; 166: 4884-4890.
134. Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 2004; 172: 1009-1017.
135. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 2000; 164: 2978-2986.
136. + T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells. Nat Immunol 2007; 8: 1060-1066.
137. + T cells by viral and tumor antigens is a robust phenomenon. Eur J Immunol 2004; 34: 194-199.
138. Kundig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M, Lother H et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995; 268: 1343-1347.
139. Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001; 411: 1058-1064.
140. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305-317.
141. Freigang S, Eschli B, Harris N, Geuking M, Quirin K, Schrempf S et al. A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses. Proc Natl Acad Sci USA 2007; 104: 13426-13431.
142. Gasteiger G, Kastenmuller W, Ljapoci R, Sutter G, Drexler I. Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol 2007; 81: 11925-11936.
143. Thomas AM, Santarsiero LM, Lutz ER, Armstrong TD, Chen YC, Huang LQ et al. Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients. J Exp Med 2004; 200: 297-306.
144. Valmori D, Souleimanian NE, Tosello V, Bhardwaj N, Adams S, O'Neill D et al. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/ Th1 responses and CD8 T cells through cross-priming. Proc Natl Acad Sci USA 2007; 104: 8947-8952.
145. el-Shami K, Tirosh B, Bar-Haim E, Carmon L, Vadai E, Fridkin M et al. MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope. Eur J Immunol 1999; 29: 3295-3301.
146. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY et al. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 2005; 25: 3620-3629.
147. Krishnamurthy B, Dudek NL, McKenzie MD, Purcell AW, Brooks AG, Gellert S et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 2006; 116: 3258-3265.
148. Yamanouchi J, Verdaguer J, Han B, Amrani A, Serra P, Santamaria P. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J Immunol 2003; 171: 6900-6909.